Discure Technologies
Reversing Degenerative Disc Disease
Company Overview
Snapshot
Founded in February 2021 by Yossi Gross, Discure Technologies is a Health Tech & Life Sciences company with 11–50 employees. The company has raised $21,000,000 across three funding rounds from seven investors.
Business overview
Discure Technologies is focused on developing a minimally invasive device designed to treat and reverse degenerative disc disease. Its core technology aims to reduce pain and restore functionality for patients, providing an alternative to invasive surgery and potentially reducing reliance on opioids. The company operates within the Health Tech & Life Sciences sector, specifically targeting medical devices and medical treatment & therapeutics markets, serving patients and healthcare providers.
Strategic signal
This funding indicates continued investor confidence in Discure Technologies' innovative approach to treating degenerative disc disease and provides capital for advancing its minimally invasive device, signaling potential for significant market disruption in the medical device and treatment sectors.
Company Intelligence Q&A
- What is Discure Technologies' primary focus?
- Discure Technologies is developing a minimally invasive device to treat and reverse degenerative disc disease, aiming to reduce pain and restore functionality without invasive surgery.
- When was Discure Technologies founded?
- Discure Technologies was founded in February 2021.
- Who are the founders of Discure Technologies?
- Yossi Gross is a founder of Discure Technologies.
- Which investors participated in the September 2024 A Round?
- The September 2024 A Round saw participation from Bold Capital Partners.